TY - JOUR
T1 - Regulatory B cells induce formation of IL-10-expressing T cells in mice with autoimmune neuroinflammation
AU - Pennati, Andrea
AU - Ng, Spencer
AU - Wu, Yuanqiang
AU - Murphy, Jordan R.
AU - Deng, Jiusheng
AU - Rangaraju, Srikant
AU - Asress, Seneshaw
AU - Blanchfield, Jennifer L.
AU - Evavold, Brian
AU - Galipeau, Jacques
N1 - Publisher Copyright:
© 2016 the authors.
PY - 2016/12/14
Y1 - 2016/12/14
N2 - Although B cells are traditionally known for their role in propagating proinflammatory immune responses, their immunosuppressive effects have only recently begun to be appreciated. How these regulatory B cells (Bregs) suppress the immune response remains to be worked out in detail. In this article, we show that Bregs can induce the formation of conventional FoxP3+regulatory T cells (Tregs), as well as a more recently described CD49b+CD223+ regulatory T-cell subset, known as type 1 regulatory T cells (Tr1s). When Bregs are transferred into mice with experimental autoimmune encephalomyelitis (EAE), a mouse model of multiple sclerosis, they home to the spleen and mesenteric lymph nodes, leading to an expansion of Tregs and Tr1 in vivo. Tregs and Tr1s are also found in greater proportions in the CNS of mice with EAE treated with Bregs and are correlated with the remission of symptoms. The discovery that Bregs induce the formation of regulatory T-cell subsets in vivo may herald their use as immunosuppressive agents in adoptive cellular therapies for autoimmune pathologies.
AB - Although B cells are traditionally known for their role in propagating proinflammatory immune responses, their immunosuppressive effects have only recently begun to be appreciated. How these regulatory B cells (Bregs) suppress the immune response remains to be worked out in detail. In this article, we show that Bregs can induce the formation of conventional FoxP3+regulatory T cells (Tregs), as well as a more recently described CD49b+CD223+ regulatory T-cell subset, known as type 1 regulatory T cells (Tr1s). When Bregs are transferred into mice with experimental autoimmune encephalomyelitis (EAE), a mouse model of multiple sclerosis, they home to the spleen and mesenteric lymph nodes, leading to an expansion of Tregs and Tr1 in vivo. Tregs and Tr1s are also found in greater proportions in the CNS of mice with EAE treated with Bregs and are correlated with the remission of symptoms. The discovery that Bregs induce the formation of regulatory T-cell subsets in vivo may herald their use as immunosuppressive agents in adoptive cellular therapies for autoimmune pathologies.
UR - https://www.scopus.com/pages/publications/85006256577
U2 - 10.1523/JNEUROSCI.1994-16.2016
DO - 10.1523/JNEUROSCI.1994-16.2016
M3 - Article
C2 - 27821578
AN - SCOPUS:85006256577
SN - 0270-6474
VL - 36
SP - 12598
EP - 12610
JO - Journal of Neuroscience
JF - Journal of Neuroscience
IS - 50
ER -